BUZZ — Australia's Telix set for best week in 7 months after FDA nod for drug

* Shares of Telix Pharmaceuticals gain as much as 3.8% to A$18.110 * Stock on track to log 14.6% gain for the week, its strongest since the week ended February 20 * Biopharma co said on Monday the US Food and Drug Administration approved its Pixclara drug * Pixclara is a radioactive diagnostic drug for imaging gliomas, a kind of brain cancer * YTD, stock has gained over 60% (Reporting by Rudrannsh Mehra in Bengaluru) ((Rudrannsh.Mehra@thomsonreuters.com)